DNA damage response as biomarkers informing a precision medicine approach to bladder cancer: what are the next steps?

被引：0
|
作者：
Niglio, Scot [1 ]
Galsky, Matthew D. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Div Hematol Oncol, Dept Med, 1 Gustave L Levy Pl, New York, NY 10029 USA
来源：
EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT | 2019年 / 4卷 / 01期
关键词：
Bladder cancer; urothelial cancer; DNA damage response; DDR; check point blockade; program cell death ligand 1; cytotoxic T-lymphocyte-associated protein 4; PD-L1; PD-1; CTLA4; ERCC2; REPAIR GENES; CHEMOTHERAPY; LANDSCAPE;
D O I：
10.1080/23808993.2019.1539621
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：7 / 9
页数：3
相关论文
共 50 条
  • [1] Biomarkers for precision medicine in bladder cancer
    Takahiro Kojima
    Koji Kawai
    Jun Miyazaki
    Hiroyuki Nishiyama
    [J]. International Journal of Clinical Oncology, 2017, 22 : 207 - 213
  • [2] Biomarkers for precision medicine in bladder cancer
    Kojima, Takahiro
    Kawai, Koji
    Miyazaki, Jun
    Nishiyama, Hiroyuki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (02) : 207 - 213
  • [3] Utilizing biomarkers associated with cardiovascular events in atrial fibrillation: informing a precision medicine response
    Tidbury, Nicola
    Preston, Joshua
    Ding, Wern Yew
    Rivera-Caravaca, Jose Miguel
    Marin, Francisco
    Lip, Gregory Y. H.
    [J]. EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2020, 5 (05): : 331 - 345
  • [4] The challenge of matching assays to biology in DNA damage response biomarkers for response to radiotherapy in bladder cancer
    Desai, Neil B.
    Bagrodia, Aditya
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 : S514 - S516
  • [5] Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer
    Meehan, James
    Gray, Mark
    Martinez-Perez, Carlos
    Kay, Charlene
    Pang, Lisa Y.
    Fraser, Jennifer A.
    Poole, Amy V.
    Kunkler, Ian H.
    Langdon, Simon P.
    Argyle, David
    Turnbull, Arran K.
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [6] Targeting DNA damage repair precision medicine strategies in cancer
    Brownlie, Juliette
    Kulkarni, Sanat
    Algethami, Mashael
    Jeyapalan, Jennie N.
    Mongan, Nigel P.
    Rakha, Emad A.
    Madhusudan, Srinivasan
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2023, 70
  • [7] DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine
    Fatemi, Nayeralsadat
    Tierling, Sascha
    Es, Hamidreza Aboulkheyr
    Varkiani, Maryam
    Mojarad, Ehsan Nazemalhosseini
    Aghdaei, Hamid Asadzadeh
    Walter, Joern
    Totonchi, Mehdi
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (12) : 2068 - 2081
  • [8] A precision medicine approach to bladder cancer using patient derived organoids
    Saadat, P.
    Thomas, P.
    Alinezhad, S.
    Williams, E.
    Vela, I.
    [J]. BJU INTERNATIONAL, 2020, 125 : 105 - 105
  • [9] Measures of DNA damage and bladder cancer cell treatment response
    Bowman, K. J.
    Al Moneef, M.
    Sherwood, B. T.
    Kockelbergh, R. C.
    Symonds, R. P.
    Steward, W. P.
    Colquhoun, A. J.
    Goddard, J. C.
    Payne, D.
    Singh, S.
    Griffiths, T. R. L.
    Khan, M. A.
    Summerton, D. J.
    Butterworth, P. C.
    McKelvey-Martin, V. J.
    McKeown, S. R.
    Mellon, J. K.
    Jones, G. D. D.
    [J]. MUTAGENESIS, 2012, 27 (01) : 104 - 104
  • [10] Correlation between genomic aberrations and the DNA damage response in bladder cancer
    Schepeler, Troels
    Lamy, Philippe
    Laurberg, Jens
    Fristrup, Niels
    Bartkova, Jirina
    Hvidbjerg, Vibeke
    Tropia, Laurence
    Bartek, Jiri
    Halazonetis, Thanos D.
    Reinert, Thomas
    Borre, Michael
    Dyrskjot, Lars
    Orntoft, Torben F.
    [J]. CANCER RESEARCH, 2012, 72
12345